The safety and efficacy of enfuvirtide therapy for HIV infection in patients with hemophilia: a case series.
case_series · Level IV
Where this comes from
- Record sourced from PubMed, PMID 17638184.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The treatment of patients with human immunodeficiency virus (HIV) infection and hemophilia involves unique challenges that may be addressed with novel antiretroviral classes. We describe the safety and efficacy of enfuvirtide therapy in 4 patients with severe hemophilia A. Although local skin reactions were common, neither local nor systemic bleeding worsened. Three patients achieved undetectable HIV loads with enfuvirtide salvage regimens.
Medical subject headings
- HIV Envelope Protein gp41
- HIV Fusion Inhibitors
- HIV Infections
- Hemophilia A
- Peptide Fragments